Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety, Tolerability and Immunogenicity of Meningococcal C Conjugate Vaccine to Children 32 to 40 Months of Age
This study has been completed.
Study NCT00310635   Information provided by Novartis
First Received: April 3, 2006   Last Updated: October 25, 2006   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Meningococcal Infection
Additional conditions recognized in this trial
Communicable Diseases
Infection
Meningococcal Infections
More general conditions related to this trial
Bacterial Infections
Gram-Negative Bacterial Infections
Neisseriaceae Infections
Interventions listed in this trial
Meningococcal C conjugate vaccine
Sponsors listed in this trial
Novartis
Novartis Vaccines


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services